Neurotoxicity of Intrathecal Methotrexate: MR Imaging Findings

References

1. ↵
   Haskell CM, Rosen L. Antineoplastic agents. In: Haskell CM, ed. Cancer Treatment. 5th ed. Philadelphia: Saunders;2001 :176–181
2. ↵
   Mahoney DH, Shuster JJ, Nitschke R, et al. Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy: a Pediatric Oncology Group study. J Clin Oncol 1998;16:1712–1722

   Abstract
3. ↵
   Lo Nigro L, Di Cataldo A, Schiliro G. Acute neurotoxicity in children with B-lineage acute lymphoblastic leukemia (B-ALL) treated with intermediate risk protocols. Med Pediatr Oncol 2000;35:449–455

   CrossRefPubMedWeb of Science
4. ↵
   Drachtman RA, Cole PD, Golden CB, et al. Dextromethorphan is effective in the treatment of subacute methotrexate neurotoxicity. Pediatr Hematol Oncol 2002;19:319–327

   CrossRefPubMedWeb of Science
5. ↵
   Quinn CT, Griener JC, Bottiglieri T, et al. Elevation of homocysteine and excitatory amino acid neurotransmitters in the CSF of children who receive methotrexate for the treatment of cancer. J Clin Oncol 1997;15:2800–2806

   Abstract
6. ↵
   Davidson A, Payne G, Leach MO, et al. Proton magnetic resonance spectroscopy ([1]H-MRS) of the brain following high-dose methotrexate treatment for childhood cancer. Med Pediatr Oncol 2000;35:28–34

   CrossRefPubMed
7. ↵
   Osterlundh G, Bjure J, Lannering B, et al. Studies of cerebral blood flow in children with acute lymphoblastic leukemia: case reports of six children treated with methotrexate examined by single photon emission computed tomography. J Pediatr Hematol Oncol 1997;19:28–34

   CrossRefPubMedWeb of Science
8. ↵
   Harila-Saari AH, Ahonen AK, Vainionpaa LK, et al. Brain perfusion after treatment of childhood acute lymphoblastic leukemia. J Nucl Med 1997;38:82–88

   Abstract/FREE Full Text
9. ↵
   Karabacak NI, Ozturk G, Gucuyener K, et al. Assessment of brain perfusion by 99m Tc-HMPAO SPECT in akinetic mutism due to high-dose intravenous methotrexate therapy. Childs Nerv Syst 1997;13:560–562

   CrossRefPubMed